We found 146 records for "Licensing / acquisition"

Articles

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

UCB looks ahead to next phase

2nd June 2014

 UCB looks ahead to next phaseArticles

As UCB marks 10 years in the UK with a special event at its research centre in Slough, Andrew McConaghie talks to chief executive Roch Doliveux about the company's future.Ten...

Read more

News

BioMarin offers $840m for muscular dystrophy firm Prosensa

25th November 2014

 BioMarin offers $840m for muscular dystrophy firm ProsensaNews

Rare disease specialist BioMarin has agreed to acquire Prosensa and its Duchenne muscular dystrophy (DMD) candidate drisapersen in a deal valued at up to around $840 million. The US company...

Read more

Pfizer-Merck cancer deal reduces likelihood of AZ merger

18th November 2014

 Pfizer-Merck cancer deal reduces likelihood of AZ mergerNews

Pfizer has announced an agreement with Merck to co-develop a novel anti-PD-L1 antibody for various cancers.Merck will receive an initial payment of $850 million, with further payments of up to...

Read more

Dendreon files for bankruptcy as Provenge falters

11th November 2014

 Dendreon files for bankruptcy as Provenge faltersNews

Despite its best efforts to streamline and transform itself into a good buy for prospective purchasers, biotech Dendreon has had no offers and has had to file for Chapter 11...

Read more

AZ nails immunotherapy colours to Imbruvica's mast

4th November 2014

 AZ nails immunotherapy colours to Imbruvica's mastNews

AstraZeneca has sealed a deal to combine its MEDI4736 immunotherapy candidate with Janssen's fast-growing leukaemia therapy Imbruvica.Launched earlier this year in the US, Janssen's drug is set to be a...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Audio & Video

Dec 8th: Live webinar - The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

International Conference Partnership Valuations in Pharma

1st December 2014 - 2nd December 2014

International Conference Partnership Valuations in Pharma

The only international event focusing on the valuation of partnerships in pharma and biotech, offering best practice examples and interactive professional exchange with experts from industry and science. - Learn from...

Read more

Generics Labeling 2014

3rd December 2014 - 4th December 2014

Generics Labeling 2014

Building on the success of the marcus evans generic pharmaceuticals series, the Generics Labeling 2014 Conference will bring together executives charged with navigating various facets of pharmaceutical labeling and regulatory...

Read more

Asia Pacific Healthcare Policy Summit 2014

4th December 2014 - 5th December 2014

Asia Pacific Healthcare Policy Summit 2014

With a population skyrocketing towards 4 billion people as well as rapid economic growth, the healthcare industries in the Asia Pacific region are set to overtake those in the West....

Read more

Genesis 2014

9th December 2014

Genesis 2014

#ongenesis2014 The life sciences industry is continually changing. The whole issue of cost containment, reimbursement and personalised medicine development is the key to the healthcare industry in the next 20 years. Now...

Read more